What is Datavant?
Datavant is a privately owned computer software company founded in 2017 and headquartered in San Francisco, California. The company specializes in linking and sharing healthcare data across multiple platforms, aiming to enhance medical research and improve patient care. Datavant also provides robust solutions for data safety and sharing operations, positioning itself as a critical infrastructure provider in the health tech ecosystem.
How much funding has Datavant raised?
Datavant has raised a total of $121M across 3 funding rounds:
Series A
$40.5M
Other Financing Round
$40.5M
Series B
$40M
Series A (2018): $40.5M with participation from Roivant Sciences
Other Financing Round (2018): $40.5M led by Roivant Sciences
Series B (2020): $40M supported by Johnson & Johnson Innovation – JJDC, Inc., Roivant Sciences Ltd., Flex Capital, Cigna Ventures, and Transformation Capital Group Ltd
Key Investors in Datavant
Roivant Sciences
Founded in 2014 and headquartered in London, Roivant Sciences is a tech-enabled healthcare company focused on completing the development of promising late-stage drug candidates and delivering innovative healthcare technologies to patients.
Johnson & Johnson Innovation – JJDC, Inc.
Johnson & Johnson Innovation – JJDC, Inc. is the venture capital arm of Johnson & Johnson, focused on investing in early-stage companies that align with Johnson & Johnson's strategic interests in healthcare and life sciences.
Flex Capital
Flex Capital is an investment firm that likely focuses on providing strategic capital to companies within the technology and healthcare sectors, supporting their growth and market penetration.
What's next for Datavant?
The substantial enterprise-level funding Datavant has attracted indicates a strong market validation and positions the company for accelerated growth and expansion. This capital infusion is expected to fuel further development of its data-linking technologies, enhance its data security protocols, and broaden its reach within the healthcare industry. Datavant's strategic focus on improving data interoperability and research capabilities suggests a trajectory aimed at becoming a foundational element in the future of healthcare innovation.
See full Datavant company page
